Propagation of dysbindin-1B aggregates: Exosome-mediated transmission of neurotoxic deposits

Neuroscience

Volumn 291, Issue , 2015, Pages 301-316

  Zhu, C Y ^a   Shen, Y ^a   Xu, Q ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Aggregation; Chronic mental diseases; Dysbindin; Neurotoxicity; Propagation

Indexed keywords

DYSBINDIN; DYSBINDIN 1B; UNCLASSIFIED DRUG; DTNBP1 PROTEIN, HUMAN; DYSTROPHIN ASSOCIATED PROTEIN; PROTEIN AGGREGATE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL INVASION; COGNITIVE DEFECT; CONTROLLED STUDY; EMBRYO; EXOSOME; MENTAL DISEASE; MOUSE; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN HOMEOSTASIS; PROTEIN TRANSPORT; ANIMAL; APOPTOSIS; BRAIN; C57BL MOUSE; CELL CULTURE; CELL SURVIVAL; COCULTURE; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; NERVE CELL; PHYSIOLOGY; PROTEINOSIS; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; BRAIN; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; DYSTROPHIN-ASSOCIATED PROTEINS; EXOSOMES; HEK293 CELLS; HUMANS; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; PROTEIN AGGREGATES; PROTEIN AGGREGATION, PATHOLOGICAL; TRANSFECTION;

EID: 84924135550     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.02.016     Document Type: Article

References (49)

1. Aguzzi A., Rajendran L. The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 2009, 64:783-790.
2. Atkin T., Kittler J. DISC1 and the aggresome: a disruption to cellular function?. Autophagy 2012, 8:851-852.
3. Atkin T.A., Brandon N.J., Kittler J.T. Disrupted in Schizophrenia 1 forms pathological aggresomes that disrupt its function in intracellular transport. Hum Mol Genet 2012, 21:2017-2028.
4. Bader V., Ottis P., Pum M., Huston J.P., Korth C. Generation, purification, and characterization of cell-invasive DISC1 protein species. J Vis Exp 2012, e4132.
5. Bader V., Tomppo L., Trossbach S.V., Bradshaw N.J., Prikulis I., Leliveld S.R., Lin C.Y., Ishizuka K., Sawa A., Ramos A., Rosa I., Garcia A., Requena J.R., Hipolito M., Rai N., Nwulia E., Henning U., Ferrea S., Luckhaus C., Ekelund J., Veijola J., Jarvelin M.R., Hennah W., Korth C. Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits. Hum Mol Genet 2012, 21:4406-4418.
6. Basso M., Pozzi S., Tortarolo M., Fiordaliso F., Bisighini C., Pasetto L., Spaltro G., Lidonnici D., Gensano F., Battaglia E., Bendotti C., Bonetto V. Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J Biol Chem 2013, 288:15699-15711.
7. Bellingham S.A., Guo B.B., Coleman B.M., Hill A.F. Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?. Front Physiol 2012, 3:124.
8. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991, 82:239-259.
9. Bradshaw N.J., Bader V., Prikulis I., Lueking A., Mullner S., Korth C. Aggregation of the protein TRIOBP-1 and its potential relevance to schizophrenia. PLoS One 2014, 9:e111196.
10. Brandon N.J., Sawa A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci 2011, 12:707-722.
11. Breen G., Prata D., Osborne S., Munro J., Sinclair M., Li T., Staddon S., Dempster D., Sainz R., Arroyo B., Kerwin R.W., St Clair D., Collier D. Association of the dysbindin gene with bipolar affective disorder. Am J Psychiatry 2006, 163:1636-1638.
12. Carr G.V., Jenkins K.A., Weinberger D.R., Papaleo F. Loss of dysbindin-1 in mice impairs reward-based operant learning by increasing impulsive and compulsive behavior. Behav Brain Res 2013, 241:173-184.
13. Costanzo M., Abounit S., Marzo L., Danckaert A., Chamoun Z., Roux P., Zurzolo C. Transfer of polyglutamine aggregates in neuronal cells occurs in tunneling nanotubes. J Cell Sci 2013, 126:3678-3685.
14. Danzer K.M., Kranich L.R., Ruf W.P., Cagsal-Getkin O., Winslow A.R., Zhu L., Vanderburg C.R., McLean P.J. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener 2012, 7:42.
15. Feng Y.Q., Zhou Z.Y., He X., Wang H., Guo X.L., Hao C.J., Guo Y., Zhen X.C., Li W. Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia. Schizophr Res 2008, 106:218-228.
16. Ghiani C.A., Dell'Angelica E.C. Dysbindin-containing complexes and their proposed functions in brain: from zero to (too) many in a decade. ASN Neuro 2011, 3.
17. Ghidoni R., Benussi L., Binetti G. Exosomes: the Trojan horses of neurodegeneration. Med Hypotheses 2008, 70:1226-1227.
18. Goldman-Rakic P.S. The cortical dopamine system: role in memory and cognition. Adv Pharmacol 1998, 42:707-711.
19. Guo J.L., Lee V.M. Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med 2014, 20:130-138.
20. Hashimoto R., Noguchi H., Hori H., Ohi K., Yasuda Y., Takeda M., Kunugi H. Association between the dysbindin gene (DTNBP1) and cognitive functions in Japanese subjects. Psychiatry Clin Neurosci 2009, 63:550-556.
21. Hattori S., Murotani T., Matsuzaki S., Ishizuka T., Kumamoto N., Takeda M., Tohyama M., Yamatodani A., Kunugi H., Hashimoto R. Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Biochem Biophys Res Commun 2008, 373:298-302.
22. Jentsch J.D., Trantham-Davidson H., Jairl C., Tinsley M., Cannon T.D., Lavin A. Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice. Neuropsychopharmacology 2009, 34:2601-2608.
23. Ji Y., Yang F., Papaleo F., Wang H.X., Gao W.J., Weinberger D.R., Lu B. Role of dysbindin in dopamine receptor trafficking and cortical GABA function. Proc Natl Acad Sci U S A 2009, 106:19593-19598.
24. Jucker M., Walker L.C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 2013, 501:45-51.
25. Kirkpatrick B., Xu L., Cascella N., Ozeki Y., Sawa A., Roberts R.C. DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J Comp Neurol 2006, 497:436-450.
26. Korth C. Aggregated proteins in schizophrenia and other chronic mental diseases: DISC1opathies. Prion 2012, 6:134-141.
27. Kozin S.A., Cheglakov I.B., Ovsepyan A.A., Telegin G.B., Tsvetkov P.O., Lisitsa A.V., Makarov A.A. Peripherally applied synthetic peptide isoAsp7-Abeta (1-42) triggers cerebral beta-amyloidosis. Neurotox Res 2013, 24:370-376.
28. Leliveld S.R., Bader V., Hendriks P., Prikulis I., Sajnani G., Requena J.R., Korth C. Insolubility of disrupted-in-schizophrenia 1 disrupts oligomer-dependent interactions with nuclear distribution element 1 and is associated with sporadic mental disease. J Neurosci 2008, 28:3839-3845.
29. Leliveld S.R., Hendriks P., Michel M., Sajnani G., Bader V., Trossbach S., Prikulis I., Hartmann R., Jonas E., Willbold D., Requena J.R., Korth C. Oligomer assembly of the C-terminal DISC1 domain (640-854) is controlled by self-association motifs and disease-associated polymorphism S704C. Biochemistry 2009, 48:7746-7755.
30. Luk K.C., Kehm V.M., Zhang B., O'Brien P., Trojanowski J.Q., Lee V.M. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 2012, 209:975-986.
31. Murotani T., Ishizuka T., Hattori S., Hashimoto R., Matsuzaki S., Yamatodani A. High dopamine turnover in the brains of sandy mice. Neurosci Lett 2007, 421:47-51.
32. Ottis P., Bader V., Trossbach S.V., Kretzschmar H., Michel M., Leliveld S.R., Korth C. Convergence of two independent mental disease genes on the protein level: recruitment of dysbindin to cell-invasive disrupted-in-schizophrenia 1 aggresomes. Biol Psychiatry 2011, 70:604-610.
33. Oueslati A., Ximerakis M., Vekrellis K. Protein transmission, seeding and degradation: key steps for alpha-synuclein prion-like propagation. Exp Neurobiol 2014, 23:324-336.
34. Papaleo F., Burdick M.C., Callicott J.H., Weinberger D.R. Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans. Mol Psychiatry 2014, 19:311-316.
35. Papaleo F., Yang F., Garcia S., Chen J., Lu B., Crawley J.N., Weinberger D.R. Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Mol Psychiatry 2012, 17:85-98.
36. Rajendran L., Honsho M., Zahn T.R., Keller P., Geiger K.D., Verkade P., Simons K. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A 2006, 103:11172-11177.
37. Rey N.L., Petit G.H., Bousset L., Melki R., Brundin P. Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol 2013, 126:555-573.
38. Schneider A., Simons M. Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders. Cell Tissue Res 2013, 352:33-47.
39. Schnupf P., Portnoy D.A., Decatur A.L. Phosphorylation, ubiquitination and degradation of listeriolysin O in mammalian cells: role of the PEST-like sequence. Cell Microbiol 2006, 8:353-364.
40. Shih J.C., Chen K., Geha R.M. Determination of regions important for monoamine oxidase (MAO) A and B substrate and inhibitor selectivities. J Neural Transm Suppl 1998, 52:1-8.
41. Shintani N., Onaka Y., Hashimoto R., Takamura H., Nagata T., Umeda-Yano S., Mouri A., Mamiya T., Haba R., Matsuzaki S., Katayama T., Yamamori H., Nakazawa T., Nagayasu K., Ago Y., Yagasaki Y., Nabeshima T., Takeda M., Hashimoto H. Behavioral characterization of mice overexpressing human dysbindin-1. Mol Brain 2014, 7:74.
42. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., Cesare A.J., Gibberman A., Wang X., O'Neill F.A., Walsh D., Kendler K.S. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002, 71:337-348.
43. Takalo M., Salminen A., Soininen H., Hiltunen M., Haapasalo A. Protein aggregation and degradation mechanisms in neurodegenerative diseases. Am J Neurodegener Dis 2013, 2:1-14.
44. Talbot K. The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia research. Prog Brain Res 2009, 179:87-94.
45. Talbot K., Louneva N., Cohen J.W., Kazi H., Blake D.J., Arnold S.E. Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location. PLoS One 2011, 6:e16886.
46. Thery C., Amigorena S., Raposo G., Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006, (Chapter 3: Unit 3 22).
47. van Haren N.E., Cahn W., Hulshoff Pol H.E., Kahn R.S. Schizophrenia as a progressive brain disease. Eur Psychiatry 2008, 23:245-254.
48. Wang L., Mamah D., Harms M.P., Karnik M., Price J.L., Gado M.H., Thompson P.A., Barch D.M., Miller M.I., Csernansky J.G. Progressive deformation of deep brain nuclei and hippocampal-amygdala formation in schizophrenia. Biol Psychiatry 2008, 64:1060-1068.
49. Yerabham A.S., Weiergraber O.H., Bradshaw N.J., Korth C. Revisiting disrupted-in-schizophrenia 1 as a scaffold protein. Biol Chem 2013, 394:1425-1437.